Jackyenjoyphotography/Getty Images
When it comes to boosting bodily functions, peptides often surface as a promising yet complex option. These short chains of amino acids, extracted from plants or animals, are engineered for specific roles—ranging from tissue repair to metabolic regulation. While they are not a magic bullet for shedding 100 pounds or turning back the clock, research-backed peptides can support a range of physiological processes. Below, we outline 12 peptides that have shown measurable benefits in clinical or pre‑clinical studies. Remember, this overview is for educational purposes only; always consult a qualified medical professional before incorporating any peptide into your regimen.
luchschenF/Shutterstock
BPC‑157, a 15‑amino‑acid fragment derived from gastric juice, is one of the most studied healing peptides. It promotes angiogenesis, thereby improving blood flow to damaged tissues and accelerating recovery. Animal trials demonstrate efficacy in tendon repair, burn healing, ulcer reduction, and even ocular conditions such as glaucoma. A 2009 study on periodontitis‑affected rats showed BPC‑157 decreased inflammation and slowed bone loss in the jaw. While BPC‑157 is not FDA‑approved and is banned by the World Anti‑Doping Agency, its extensive pre‑clinical data suggest it may aid tissue regeneration when used responsibly.
Guido Mieth/Getty Images
GHK‑Cu (glycyl‑L‑histidyl‑L‑lysine plus copper) is naturally present in plasma, saliva, and urine. It serves as a signaling molecule that stimulates collagen production and vascular growth, making it a popular component in anti‑aging skincare. Human and animal studies confirm GHK‑Cu’s role in repairing skin, bone, and liver tissue, as well as reducing oxidative stress. Moreover, research indicates potential neuroprotective effects, including mitigation of cognitive decline in aged mice. Because GHK‑Cu is widely available in cosmetic formulations, consumers can verify authenticity by checking for the characteristic blue copper tint.
Iuliia Burmistrova/Getty Images
Glucagon‑like peptide‑1 (GLP‑1) is an endogenous hormone released during digestion. It stimulates insulin secretion, slows gastric emptying, and reduces appetite—mechanisms that underpin its FDA‑approved use for type 2 diabetes and obesity (e.g., Ozempic, Trulicity, Saxenda). Recent clinical investigations have explored GLP‑1 analogs for binge‑eating disorder, depression, substance‑use disorders, and sexual dysfunction, with promising early results. As a clinically validated peptide, GLP‑1 offers a multifaceted approach to metabolic and neuropsychiatric health.
Cynthia A Jackson/Shutterstock
Glucose‑dependent insulinotropic polypeptide (GIP) complements GLP‑1 by stimulating insulin release. While GIP alone can promote fat storage, it is typically combined with GLP‑1 analogs to enhance weight‑loss outcomes. Tirzepatide (Mounjaro/Zepbound) and retatrutide represent dual or triple agonists that target GIP, GLP‑1, and glucagon receptors, respectively. Clinical trials show tirzepatide outperforms semaglutide in reducing body weight and improving glycemic control. Beyond metabolism, GIP research suggests roles in cancer biomarker detection, bone health, and spinal cord injury recovery.
Doucefleur/Shutterstock
Tesamorelin is a synthetic, high‑potency version of growth‑hormone‑releasing hormone (GHRH). It elevates insulin‑like growth factor‑1 (IGF‑1) and endogenous growth hormone, counteracting lipodystrophy and reducing non‑alcoholic fatty liver disease in HIV patients. In non‑HIV cohorts, tesamorelin has shown benefits for nerve regeneration, muscle preservation after injury, and early‑stage dementia cognition. Administered subcutaneously, tesamorelin’s safety profile has been well documented in multiple peer‑reviewed studies.
PeopleImages.com – Yuri A/Shutterstock
MOTS‑c, a mitochondrial‑derived 12‑S rRNA peptide, mimics exercise’s metabolic benefits. Research highlights improved insulin sensitivity, reduced age‑related inflammation, enhanced heart function, and protection against osteoporosis. Its anti‑aging properties extend to type 1 and type 2 diabetes management. Though banned by the World Anti‑Doping Agency, MOTS‑c is gaining traction in the body‑recomposition community for its potential to enhance energy metabolism and tissue repair.
Yuichiro Chino/Getty Images
Melanotan 2 (MT‑II) is a synthetic analog of α‑melanocyte‑stimulating hormone that activates melanocortin receptors. It induces skin pigmentation, boosts libido via MC‑4R, and influences appetite regulation. While its tanning effect is transient and carries a melanoma risk, MT‑II has been studied for neuroprotection (Alzheimer’s, Parkinson’s), autism spectrum symptom reversal in mice, and sexual dysfunction in both sexes. Clinical relevance remains limited, but ongoing research continues to explore its therapeutic potential.
Jun/Getty Images
CJC‑1295 is a synthetic analog of GHRH that increases plasma growth hormone and IGF‑1 levels while extending the hormone’s half‑life. It is favored by athletes and biohackers for muscle recovery and anti‑aging effects. Epidemiological analysis of online forums suggests benefits in injury recovery, mood enhancement, and skin rejuvenation. Pre‑clinical trials confirm CJC‑1295 stimulates pituitary activity and may aid growth disorders in pediatric populations.
Guido Mieth/Getty Images
Delta‑sleep‑inducing peptide (DSIP) originates in the hypothalamus and influences pituitary hormones. Though its exact sleep‑promoting mechanism is unclear, DSIP has shown efficacy in treating chronic insomnia, major depressive disorder, and seizure reduction. Additional studies report analgesic effects and potential lifespan extension in animal models. DSIP’s therapeutic spectrum continues to expand across neurological and stress‑related conditions.
PeopleImages.com – Yuri A/Shutterstock
TB‑500 is a synthetic variant of thymosin β‑4, a 43‑amino‑acid protein involved in actin polymerization. It facilitates cell migration, tissue repair, and vascular remodeling. TB‑4 has demonstrated benefits in neural regeneration, spinal cord injury healing, cardiovascular repair, and hair growth. While primarily studied in animal models, its multifunctional role makes TB‑500 a candidate for broad tissue‑repair applications.
Kieferpix/Getty Images
Ipamorelin, a pentapeptide that mimics ghrelin, selectively stimulates growth‑hormone release without elevating cortisol. Clinical studies show it mitigates steroid‑induced bone loss, enhances bone mineral density, and supports muscle strength. Emerging research indicates potential benefits for digestive health, insulin secretion, and gastric motility. Ipamorelin’s targeted profile makes it an attractive option for individuals seeking growth‑hormone benefits with minimal side‑effects.
Unai Huizi Photography/Shutterstock
5‑Aminoimidazole‑4‑carboxamide ribonucleotide (AICAR) activates AMP‑activated protein kinase, a key regulator of cellular energy. In pre‑clinical studies, AICAR reduces intestinal ischemia injury, postoperative inflammation, lung damage from toxic gases, and cardiac stress. It also improves exercise endurance, reduces body fat, and enhances sperm motility. These findings suggest AICAR could serve as a therapeutic agent for metabolic, cardiovascular, and reproductive disorders.
These peptides represent a spectrum of scientifically validated mechanisms that may support healing, metabolic regulation, and anti‑aging. However, availability, regulatory status, and safety profiles vary. Always procure peptides from reputable suppliers that provide third‑party lab verification, and discuss any supplementation with a licensed healthcare provider.
